{"content":"<li class=\"n-box-item date-title\" data-end=\"1495857599\" data-start=\"1495771200\" data-txt=\"Monday, December 23, 2019\">Friday, May 26, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3270282\" data-ts=\"1495838877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRWI\" target=\"_blank\">DRWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270282-dragonwave-tanks-29_3-after-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DragonWave tanks 29.3% after Q4 miss</a></h4><ul>   <li>DragonWave (<a href=\"http://seekingalpha.com/symbol/DRWI\" target=\"_blank\">DRWI</a> <font color='green'>+5%</font>) has <font color='red'>slid 29.3%</font> in postmarket trading late on a pre-holiday Friday after posting <a href=\"https://seekingalpha.com/news/3270272-dragonwave-misses-0_37-misses-revenue\" target=\"_blank\">Q4 earnings</a> that significantly missed Street estimates.</li>    <li>The company swung to a gross profit, and narrowed its net loss to shareholders to $3.9M, still deeper than forecast.</li>    <li>Our results in Q4 reflect the difficult operating conditions,\" says CEO Peter Allen, adding that the firm's been working on a credit restructuring and has engaged Alvarez &amp; Marsal Canada to help find \"strategic alternatives in relation to short term liquidity requirements.</li>    <li>Revenue breakout: Hardware and other, $6.85M (down 20.4%); services, $1.11M (down 67.9%).</li>    <li>Cash and equivalents came to $4.1M.</li>    <li><a href=\"http://investor.dragonwaveinc.com/events.cfm\" target=\"_blank\">Conference call</a> to come Monday at 8:30 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16845572-dragonwave-reports-fourth-quarter-full-fiscal-year-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3270282\" data-linked=\"DragonWave tanks 29.3% after Q4 miss\" data-tweet=\"$DRWI - DragonWave tanks 29.3% after Q4 miss https://seekingalpha.com/news/3270282-dragonwave-tanks-29_3-after-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3270282-dragonwave-tanks-29_3-after-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270279\" data-ts=\"1495837122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSSLF\" target=\"_blank\">TSSLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270279-reuters-slim-looking-to-sell-minority-stake-in-tower-spin-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Slim looking to sell minority stake in tower spin-off</a></h4><ul>   <li>Carlos Slim is looking to sell a minority stake in Telesites (<a href=\"http://seekingalpha.com/symbol/TSSLF\" target=\"_blank\">TSSLF</a> <font color='green'>+3.8%</font>), the towers company spun off from telecom America Movil (<a href=\"http://seekingalpha.com/symbol/AMX\" target=\"_blank\">AMX</a> <font color='green'>+1.6%</font>), Reuters reports.</li>    <li>Slim and his family own about 61% of Telesites shares, and he's talking to private equity, sovereign wealth funds and infrastructure funds about taking a chunk of the operator, which has had trouble diversifying its business beyond America Movil and its mobile unit Telcel.</li>    <li>Telesites is capitalized at about 38.52B pesos (about $2B).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270279\" data-linked=\"Reuters: Slim looking to sell minority stake in tower spin-off\" data-tweet=\"$TSSLF $TSSLF $AMX - Reuters: Slim looking to sell minority stake in tower spin-off https://seekingalpha.com/news/3270279-reuters-slim-looking-to-sell-minority-stake-in-tower-spin-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3270279-reuters-slim-looking-to-sell-minority-stake-in-tower-spin-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270274\" data-ts=\"1495834663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270274-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='green'>+21.4%</font>. <a href='https://seekingalpha.com/symbol/APPN' title='Appian Corp.'>APPN</a> <font color='green'>+5.0%</font>. <a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a> <font color='green'>+3.6%</font>. LBIO <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+2.1%</font>.</li><li><b>Top losers:</b> SPU <font color='red'>-8.8%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-4.7%</font>. <a href='https://seekingalpha.com/symbol/CERS' title='Cerus Corporation'>CERS</a> <font color='red'>-4.6%</font>. <a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='red'>-2.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270274\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ECYT $APPN $TEAM - After Hours Gainers / Losers https://seekingalpha.com/news/3270274-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3270274-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270267\" data-ts=\"1495831590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270267-updated-data-on-endocytes-two-lead-product-candidates-to-be-presented-asco-shares-up-16-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Updated data on Endocyte&#39;s two lead product candidates to be presented at ASCO; shares up 16% after hours</a></h4><ul><li>Thinly traded micro cap Endocyte (NASDAQ:<a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a>) jumps&nbsp;<font color='green'>16%&nbsp;</font>after hours on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16845518-endocyte-announce-updated-data-ec1456-ec1169-2017-american-society-clinical-oncology-asco\" target=\"_blank\">announcement </a>that updated data on top candidates EC1456 and EC1169 will be presented at ASCO.</li><li>EC1456: results from a two-part Phase 1 study, EC1456-01. Part A (dose escalation phase) involves 87 patients with advanced solid tumors and Part B (expansion phase) six patients with FR-positive non-small lung cancer as of the May 18 cutoff. Preliminary data on the first patient enrolled in the ovarian surgical study, EC1456-02, will also be presented (Abstract #2576).</li><li>EC1169: results from a two-part Phase 1 (same design as EC1456-01) in patients with metastatic castration-resistant prostate cancer. Data includes 24 taxane-exposed patients in Part A and 16 taxane-naive patients in Part B (Abstract #5038).</li></ul><div class=\"tiny-share-widget\" data-id=\"3270267\" data-linked=\"Updated data on Endocyte&#39;s two lead product candidates to be presented at ASCO; shares up 16% after hours\" data-tweet=\"$ECYT - Updated data on Endocyte&#39;s two lead product candidates to be presented at ASCO; shares up 16% after hours https://seekingalpha.com/news/3270267-updated-data-on-endocytes-two-lead-product-candidates-to-be-presented-asco-shares-up-16-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3270267-updated-data-on-endocytes-two-lead-product-candidates-to-be-presented-asco-shares-up-16-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270263\" data-ts=\"1495831295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270263-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/SIVR' title='ETFS Physical Silver Trust ETF'>SIVR</a> <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a> <font color='green'>+2.8%</font>. <a href='https://seekingalpha.com/symbol/IDU' title='iShares U.S. Utilities ETF'>IDU</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='green'>+2.5%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-8.1%</font>. <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='red'>-4.0%</font>. <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/AMJ' title='JPMorgan Alerian MLP Index ETN'>AMJ</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a> <font color='red'>-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270263\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$SLV $SIVR $PSLV - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3270263-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3270263-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270250\" data-ts=\"1495827111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270250-sarepta-sells-off-21-from-intermediate-high-fda-drags-feet-over-request-for-exondys-51\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta sells off 21% from intermediate high as FDA drags feet over request for Exondys 51 records</a></h4><ul><li>Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='red'>-3.9%</font>) underscores its volatile nature as it sells off over 21% from its intermediate high of $37.41 touched on May 19.</li><li>Investors are hitting the sell button in apparent response to a <a href=\"http://www.bizjournals.com/boston/news/2017/05/25/reporter-sues-fda-for-documents-related-to-sarepta.html\" target=\"_blank\">lawsuit </a>filed against the FDA by journalist and NYU professor Charles Seife. It seems the agency is reticent to disgorge internal documents related to its controversial approval of DMD med Exondys 51 (eteplirsen) that he requested under the Freedom of Information Act. His complaint accuses the regulator of dragging its feet in responding to his request, filed in December, before finally rejecting it.</li><li>Seife sought emails between top officials, including former Commissioner Robert Califf, that mention the company, Duchenne and other keywords, in addition to correspondence between Califf and editors at the journal <em>Annals of Neurology</em> which published a study in 2013 providing evidence of eteplirsen's effectiveness. Just before the FDA approved the drug, Califf called for a retraction of the study, funded by Sarepta, calling it \"misleading.\"</li><li>An FDA spokesperson stated that the agency \"does not comment on pending or ongoing litigation.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3270250\" data-linked=\"Sarepta sells off 21% from intermediate high as FDA drags feet over request for Exondys 51 records\" data-tweet=\"$SRPT - Sarepta sells off 21% from intermediate high as FDA drags feet over request for Exondys 51 records https://seekingalpha.com/news/3270250-sarepta-sells-off-21-from-intermediate-high-fda-drags-feet-over-request-for-exondys-51?source=tweet\" data-url=\"https://seekingalpha.com/news/3270250-sarepta-sells-off-21-from-intermediate-high-fda-drags-feet-over-request-for-exondys-51\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270247\" data-ts=\"1495825216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270247-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VEEV' title='Veeva Systems Inc.'>VEEV</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/WEB' title='Web.com Group, Inc'>WEB</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> DRAM <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270247\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$NTNX $VEEV $INFN - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3270247-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270247-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270246\" data-ts=\"1495825205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270246-softbank-considers-nvidia-investment-nvidiaplus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SoftBank considers further Nvidia investment; Nvidia +2%</a></h4><ul><li>Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) shares are up on <a href=\"https://www.streetinsider.com/Hedge+Funds/Softbank+Said+to+Consider+Raising+NVIDIA+%28NVDA%29+Stake+Over+Time+-+Bloomberg/12952008.html\" target=\"_blank\">news</a> that SoftBank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>) is interested in increasing its investment in the GPU design company, according to sources close to the matter. No specifics are provided.</li><li>SoftBank snagged a $4B stake in Nvidia on Wednesday. The increase would reportedly happen over time as SoftBank begins to work closely with Nvidia.</li><li>Nvidia shares are&nbsp;<font color='green'>up over 2%</font>.</li><li>SoftBank shares are&nbsp;<font color='green'>up nearly 1%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269464-softbank-takes-4b-stake-nvidia\" target=\"_blank\"><b>SoftBank takes $4B stake in Nvidia</b></a> (May 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270246\" data-linked=\"SoftBank considers further Nvidia investment; Nvidia +2%\" data-tweet=\"$NVDA $NVDA $SFTBY - SoftBank considers further Nvidia investment; Nvidia +2% https://seekingalpha.com/news/3270246-softbank-considers-nvidia-investment-nvidiaplus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3270246-softbank-considers-nvidia-investment-nvidiaplus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270239\" data-ts=\"1495821726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270239-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/VEDL' title='Vedanta Ltd'>VEDL</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270239\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$TELL $RYAM $VEDL - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3270239-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270239-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270236\" data-ts=\"1495820518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270236-bristow-downgraded-cowen-on-reduced-cash-flow-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow downgraded at Cowen on reduced cash flow outlook</a></h4><ul><li>Bristow (<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a> <font color='red'>-2.5%</font>) is <a href=\"https://www.streetinsider.com/Analyst+Comments/Cowen+Downgrades+Bristow+Group+%28BRS%29+to+Market+Perform+Citing+Secular+Headwinds/12949628.html\" target=\"_blank\">downgraded</a> to Market Perform from Outperform with a $7 price target, whacked in half from a previous $14, at Cowen, which anticipates continued cash consumption that will be needed absent a meaningful recovery in offshore drilling.</li><li>Cowen models a significant reduction to cash flow estimates, which now have BRS consuming cash through FY 2020, with the company needing to successfully defer capex and refinance or obtain new financing to support liquidity in 2020.</li><li>The BRS share price already has been cut nearly in half since reporting a larger than expected <a href=\"https://seekingalpha.com/news/3269419-bristow-eps-1_15\" target=\"_blank\">FQ4 loss</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270236\" data-linked=\"Bristow downgraded at Cowen on reduced cash flow outlook\" data-tweet=\"$BRS - Bristow downgraded at Cowen on reduced cash flow outlook https://seekingalpha.com/news/3270236-bristow-downgraded-cowen-on-reduced-cash-flow-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3270236-bristow-downgraded-cowen-on-reduced-cash-flow-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270227\" data-ts=\"1495818222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270227-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='green'>+7%</font>.<a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/RILY' title='B. Riley Financial, Inc.'>RILY</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/XIN' title='Xinyuan Real Estate Co., Ltd.'>XIN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270227\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$AFSI $SGLB $TRUP - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3270227-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270227-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270222\" data-ts=\"1495817847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCON\" target=\"_blank\">TCON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270222-tracon-pharma-perks-up-ahead-of-asco-presentations-shares-ahead-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TRACON Pharma perks up ahead of ASCO presentations; shares ahead 14%</a></h4><ul><li>Thinly traded nano cap TRACON Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='green'>+14%</font>) is up on an 80% surge in volume, although the stock is still mired in a long-term downtrend.</li><li>Yesterday after the close, it <a href=\"https://seekingalpha.com/pr/16844792-tracon-announces-clinical-data-presentations-upcoming-asco-annual-meeting\" target=\"_blank\">announced </a>four ASCO&nbsp;poster presentations on its lead candidates TRC105 and TRC102.</li><li>TRC102 (methyloxyamine HCl): Phase 1 data (with temozolomide) in solid tumors and lymphomas (Abstract #2518)</li><li>TRC105 (carotuximab): Phase 1 data (with bevacizumab) in brain cancer (#2023); biomarker modulation (in combo with anti-VEGF therapy) (#11546); Phase 3 data (with pazopanib) in angiosarcoma (#TPS11081).</li><li>TRC105 is an antibody that binds to a protein called endoglin which is overexpressed on proliferating endothelial cells that play an essential role in angiogenesis (formation of new blood vessels).</li><li>TRC102 is a small molecule inhibitor of the DNA base excision pathway, which causes resistance to certain chemo agents.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270222\" data-linked=\"TRACON Pharma perks up ahead of ASCO presentations; shares ahead 14%\" data-tweet=\"$TCON - TRACON Pharma perks up ahead of ASCO presentations; shares ahead 14% https://seekingalpha.com/news/3270222-tracon-pharma-perks-up-ahead-of-asco-presentations-shares-ahead-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3270222-tracon-pharma-perks-up-ahead-of-asco-presentations-shares-ahead-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270223\" data-ts=\"1495817104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270223-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a> <font color='green'>+18%</font>. CLNT <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/WBAI' title='500.com Limited'>WBAI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/EVLV' title='EVINE Live Inc.'>EVLV</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CCCL' title='China Ceramics Co., Ltd.'>CCCL</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a> <font color='red'>-12%</font>. DRAM <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-9%</font>. SHLD <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/BZH' title='Beazer Homes USA, Inc.'>BZH</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270223\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SENS $SEII $DECK - Midday Gainers / Losers https://seekingalpha.com/news/3270223-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3270223-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270220\" data-ts=\"1495815852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEEV\" target=\"_blank\">VEEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270220-veeva-systems-price-target-increases-following-q1-beats-up-6_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veeva Systems price target increases following Q1 beats; up 6.8%</a></h4><ul><li>Bank of America Merrill Lynch <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/05/9527024/veeva-systems-stands-on-the-brink-of-opportunity-meritin\" target=\"_blank\">upgrades</a> Veeva Systems (NYSE:<a href='https://seekingalpha.com/symbol/VEEV' title='Veeva Systems Inc.'>VEEV</a>) to Buy from Neutral and pushes the price target from $48 to $70. Analyst Brad Sills cites the 27% billings growth over the prior two quarters in his belief that cloud product Vault will become a multibillion-dollar sales generator.</li><li>Sills expects the Commercial segment to grow mid-teens on geographic expansions and utilization of current and launching customer contracts.</li><li>Canaccord analyst Richard Davis also <a href=\"https://www.streetinsider.com/Analyst+Comments/Veeva+Systems+%28VEEV%29%3A+Another+Great+Quarter%2C+Another+PT+Increase+-+Canaccord/12950514.html\" target=\"_blank\">raises</a> the price target from $48 to $70 and maintains his Buy rating. Davis writes that Veeva is &ldquo;firmly in the top decile of companies we track in terms of our confidence in the firm&rsquo;s execution, hitting numbers, sustaining growth and that increasingly in vogue thing called profitability.\"</li><li>Veeva shares are&nbsp;<font color='green'>up 7.2%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270069-veeva-systems-beats-estimates-q1-guidance-3_6-percent\" target=\"_blank\"><b>Veeva Systems beats estimates for Q1 and guidance, up 3.6%</b></a> (May 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270220\" data-linked=\"Veeva Systems price target increases following Q1 beats; up 6.8%\" data-tweet=\"$VEEV - Veeva Systems price target increases following Q1 beats; up 6.8% https://seekingalpha.com/news/3270220-veeva-systems-price-target-increases-following-q1-beats-up-6_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3270220-veeva-systems-price-target-increases-following-q1-beats-up-6_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270219\" data-ts=\"1495814900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270219-sinaplus-2_2-distributes-part-of-weibo-stake-to-holders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sina +2.2% as it distributes part of Weibo stake to holders</a></h4><ul>   <li>The board at Sina (<a href=\"http://seekingalpha.com/symbol/SINA\" target=\"_blank\">SINA</a> <font color='green'>+2.2%</font>) has signed off on the <a href=\"https://seekingalpha.com/pr/16845240-sina-announces-distribution-weibo-shares\" target=\"_blank\">distribution of shares</a> of its unit Weibo (<a href=\"http://seekingalpha.com/symbol/WB\" target=\"_blank\">WB</a> <font color='red'>-1%</font>) to shareholders, trimming its stake.</li>    <li>Sina will distribute one Weibo Class A ordinary share to the holder of each 10 Sina ordinary shares, it said; Sina ordinary holders that settle through DTC will get Class A ordinary shares represented by Weibo American Depositary Shares.</li>    <li>That will trim Sina's equity stake to 46% from 49% (and its voting power to about 72%, from a previous 74%).</li>    <li>The move is payable around July 10 to shareholders of record at the close June 7.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270219\" data-linked=\"Sina +2.2% as it distributes part of Weibo stake to holders\" data-tweet=\"$SINA $SINA $WB - Sina +2.2% as it distributes part of Weibo stake to holders https://seekingalpha.com/news/3270219-sinaplus-2_2-distributes-part-of-weibo-stake-to-holders?source=tweet\" data-url=\"https://seekingalpha.com/news/3270219-sinaplus-2_2-distributes-part-of-weibo-stake-to-holders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270218\" data-ts=\"1495814493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270218-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270218\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$DECK $CAL $NAKD - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3270218-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270218-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270210\" data-ts=\"1495811610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSG\" target=\"_blank\">INSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270210-inseegominus-4_7-cfius-extends-review-of-novatel-wireless-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inseego -4.7%; CFIUS extends review of Novatel Wireless sale</a></h4><ul>   <li>Inseego (NASDAQ:<a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a>) is <font color='red'>off 4.7%</font> to its session low, just 6% above the 52-week low it hit last week.</li>    <li>That's part of a two-day <font color='red'>decline of 6.4%</font> after news that the Committee on Foreign Investment in the United States has <a href=\"https://seekingalpha.com/pr/16843774-inseego-corp-updates-cfius-process-sale-novatel-wireless-inc\" target=\"_blank\">extended a review</a> into the company's sale of Novatel Wireless to Jade Ocean Global.</li>    <li>The 30-day review period has been extended into an investigation period that could stretch to 45 days, but Inseego believes it will wrap up by July 10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270210\" data-linked=\"Inseego -4.7%; CFIUS extends review of Novatel Wireless sale\" data-tweet=\"$INSG - Inseego -4.7%; CFIUS extends review of Novatel Wireless sale https://seekingalpha.com/news/3270210-inseegominus-4_7-cfius-extends-review-of-novatel-wireless-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3270210-inseegominus-4_7-cfius-extends-review-of-novatel-wireless-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270189\" data-ts=\"1495810948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270189-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar'>AMPH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ROSG-OLD' title='Rosetta Genomics Ltd.'>ROSG-OLD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TRIL' title='Trillium Therapeutics Inc.'>TRIL</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270189\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$SENS $AMPH $ROSG-OLD - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3270189-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3270189-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270203\" data-ts=\"1495810104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270203-reuters-arcelormittal-wins-bid-to-buy-italys-ilva-steel-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: ArcelorMittal wins bid to buy Italy&#39;s Ilva steel plant</a></h4><ul>     <li>ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+1.7%</font>) and steel processor Marcegaglia win a bid to <a href=\"http://www.reuters.com/article/us-ilva-italy-idUSKBN18M1KT\" target=\"_blank\">buy Italy's troubled Ilva steel plant</a>, Reuters reports.</li>     <li>The partners offered just under 2B ($2.24B) for the loss-making plant, Europe's biggest by output capacity, according to the report.</li>     <li>Italy's government has been trying to sell Ilva since 2015, when the state took over the plant to clean up the polluted site and save thousands of jobs in an economically depressed area.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270203\" data-linked=\"Reuters: ArcelorMittal wins bid to buy Italy&#39;s Ilva steel plant\" data-tweet=\"$MT - Reuters: ArcelorMittal wins bid to buy Italy&#39;s Ilva steel plant https://seekingalpha.com/news/3270203-reuters-arcelormittal-wins-bid-to-buy-italys-ilva-steel-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3270203-reuters-arcelormittal-wins-bid-to-buy-italys-ilva-steel-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270195\" data-ts=\"1495809969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHCAF\" target=\"_blank\">SHCAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270195-sharp-confirms-toshiba-bid-forecasts-first-net-profit-in-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sharp confirms Toshiba bid, forecasts first net profit in years</a></h4><ul><li>LCD maker Sharp Corp (<a href='https://seekingalpha.com/symbol/SHCAF' title='Sharp Corp.'>OTCPK:SHCAF</a>, <a href='https://seekingalpha.com/symbol/SHCAY' title='Sharp Corp. ADR'>OTCPK:SHCAY</a>) <a href=\"http://in.reuters.com/article/sharp-outlook-idINKBN18M0II\" target=\"_blank\">confirms</a> for the first time that the company is involved in the bidding process for Toshiba&rsquo;s (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) sought-after chip unit. Sharp will partner with parent company Foxconn (<a href='https://seekingalpha.com/symbol/FXCOF' title='FOXCONN TECH CO LTD ORD'>OTC:FXCOF</a>, <a href='https://seekingalpha.com/symbol/HNHAF' title='Hon Hai Precision Industry Co. Ltd.'>OTCPK:HNHAF</a>) for the bid but has not disclosed any financial details.</li><li>The company forecast a full-year net profit of&nbsp;&yen;59B&nbsp;($530M) up from&nbsp;&yen;24.9B&nbsp;last year and beating the consensus estimate of&nbsp;&yen;41.9B&nbsp;Sharp hopes to achieve an operating profit of&nbsp;&yen;150B&nbsp;by the fiscal year ending in March 2020.</li><li>Sharp hasn&rsquo;t reported in net profit in four years but has undergone restructuring in the wake of Foxconn&rsquo;s $3.8B acquisition last year. The return to profit will allow Sharp to move forward with more growth investments similar to the recent $1B investment in SoftBank&rsquo;s Vision Fund.</li><li>Sharp shares are&nbsp;<font color='green'>up 2.7%</font>.</li><li>Toshiba shares are&nbsp;<font color='red'>down 0.98%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270195\" data-linked=\"Sharp confirms Toshiba bid, forecasts first net profit in years\" data-tweet=\"$SHCAF $SHCAF $SHCAY - Sharp confirms Toshiba bid, forecasts first net profit in years https://seekingalpha.com/news/3270195-sharp-confirms-toshiba-bid-forecasts-first-net-profit-in-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3270195-sharp-confirms-toshiba-bid-forecasts-first-net-profit-in-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270201\" data-ts=\"1495809718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LANC\" target=\"_blank\">LANC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270201-lancaster-colony-rallies-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lancaster Colony rallies after upgrade</a></h4><ul> <li>Lancaster Colony (<a href='https://seekingalpha.com/symbol/LANC' title='Lancaster Colony Corporation'>LANC</a> <font color='green'>+4.2%</font>) trades higher after Vertical Group lifts its rating on the food stock to Buy from Hold.</li> <li>The boutique investment firm takes its price target on LANC&nbsp;up to $146 to rep 20% upside potential.</li> <li>Yesterday, Lancaster named a new CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269996-lancaster-colony-appoints-new-ceo\" target=\"_blank\">Lancaster Colony appoints new CEO</a> (May 25)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3270201\" data-linked=\"Lancaster Colony rallies after upgrade\" data-tweet=\"$LANC - Lancaster Colony rallies after upgrade https://seekingalpha.com/news/3270201-lancaster-colony-rallies-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3270201-lancaster-colony-rallies-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270192\" data-ts=\"1495807591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATBPF\" target=\"_blank\">ATBPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270192-antibe-therapeutics-prices-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antibe Therapeutics prices equity offering</a></h4><ul><li>Antibe Therapeutics (<a href='https://seekingalpha.com/symbol/ATBPF' title='Antibe Therapeutics, Inc.'>OTCQB:ATBPF</a>) <a href=\"https://seekingalpha.com/pr/16845264-antibe-therapeutics-inc-announces-pricing-offering\" target=\"_blank\">prices </a>its public offering of Units at $0.10. Each Unit consists of one share of common stock and one three-year warrant to purchase 1/2 of a common share at $0.15.</li><li>The offering will be executed on a \"best efforts\" basis in the Canadian provinces of Ontario, British Columbia and Alberta.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270192\" data-linked=\"Antibe Therapeutics prices equity offering\" data-tweet=\"$ATBPF - Antibe Therapeutics prices equity offering https://seekingalpha.com/news/3270192-antibe-therapeutics-prices-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3270192-antibe-therapeutics-prices-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270188\" data-ts=\"1495807017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270188-cytrx-continues-up-move-shares-ahead-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytRx continues up move; shares ahead 8%</a></h4><ul><li>Nano cap CytRx (<a href='https://seekingalpha.com/symbol/CYTR' title='CytRx Corporation'>CYTR</a> <font color='green'>+8.4%</font>) builds on yesterday's 21% move on slightly higher volume. Shares have rallied 56% since the company announced positive late-stage data on aldoxorubicin in treatment-resistant soft tissue sarcoma.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268474-late-stage-data-cytrxs-aldoxorubicin-sts-showed-treatment-benefit-shares-14-percent\" target=\"_blank\">Late-stage data on CytRx's aldoxorubicin in STS showed treatment benefit; shares up 14%</a> (May 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270188\" data-linked=\"CytRx continues up move; shares ahead 8%\" data-tweet=\"$CYTR - CytRx continues up move; shares ahead 8% https://seekingalpha.com/news/3270188-cytrx-continues-up-move-shares-ahead-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3270188-cytrx-continues-up-move-shares-ahead-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270179\" data-ts=\"1495804887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270179-infineraplus-3_5-wells-boosts-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera +3.5% as Wells boosts to Outperform</a></h4><ul>   <li>Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) is <font color='green'>up 3.5%</font> premarket after a move to the Buy column by Wells Fargo.</li>    <li>Analyst Jess Lubert had previously rated the stock Market Perform; the upgrade takes the optical equipment provider to Outperform.</li>    <li>Wells set a an above-average $13 price target, implying near-37% upside.</li>    <li>Several firms are Neutral on the stock, though Needham reiterated its Strong Buy earlier this month (and a $13.50 price target). Goldman Sachs also set a $13.50 target in a March upgrade.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270179\" data-linked=\"Infinera +3.5% as Wells boosts to Outperform\" data-tweet=\"$INFN - Infinera +3.5% as Wells boosts to Outperform https://seekingalpha.com/news/3270179-infineraplus-3_5-wells-boosts-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3270179-infineraplus-3_5-wells-boosts-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270178\" data-ts=\"1495804838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270178-zosano-up-6-premarket-after-execs-buy-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano up 6% premarket after execs buy shares</a></h4><ul><li>Nano cap Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>) perks up&nbsp;<font color='green'>6%</font>&nbsp;premarket on average volume. Yesterday, interim CEO John Peter Walker <a href=\"https://www.gurufocus.com/news/525361/zosano-pharma-corp-zsan-interim-ceo-john-peter-walker-bought-100254-of-shares\" target=\"_blank\">bought </a>73,716 common shares at an average price of $1.36 and CFO and Chief Business Officer Georgia Erbez purchased 68,000 shares at $1.32.</li><li>The company's lead product candidate is M207 for the treatment of migraine. It reported positive results from a Phase 3 study in February.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242827-zosanos-lead-product-candidate-successful-late-stage-migraine-study-shares-ahead-46-percent\" target=\"_blank\">Zosano's lead product candidate successful in late-stage migraine study; shares ahead 46% premarket</a> (Feb. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270178\" data-linked=\"Zosano up 6% premarket after execs buy shares\" data-tweet=\"$ZSAN - Zosano up 6% premarket after execs buy shares https://seekingalpha.com/news/3270178-zosano-up-6-premarket-after-execs-buy-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3270178-zosano-up-6-premarket-after-execs-buy-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270170\" data-ts=\"1495804739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCM\" target=\"_blank\">CMCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270170-cheetah-mobile-announces-investment-in-ai-company-shares-rise-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheetah Mobile announces investment in AI company; shares rise 1%</a></h4><ul><li>Cheetah Mobile's (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) investment in Beijing OrionStar Technology<a href=\"http://www.prnewswire.com/news-releases/cheetah-mobile-invests-in-robotics-business-300464519.html\" target=\"_blank\"> is about $40M</a> for a 29.6% equity interest.</li><li>Also China-based, Cheetah Mobile creates popular mobile applications including Battery Doctor and CM Security that attract about 600M daily active users around the world.</li><li>Cheetah is entitled to a future warrant to subscribe to a new equity interest in OrionStar with a value of up to $62M and 51.7% equity interest if exercised in full. The warrant becomes available two years after closing the current investment.</li><li>Cheetah Mobile shares are&nbsp;<font color='green'>up 1%&nbsp;</font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270170\" data-linked=\"Cheetah Mobile announces investment in AI company; shares rise 1%\" data-tweet=\"$CMCM - Cheetah Mobile announces investment in AI company; shares rise 1% https://seekingalpha.com/news/3270170-cheetah-mobile-announces-investment-in-ai-company-shares-rise-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3270170-cheetah-mobile-announces-investment-in-ai-company-shares-rise-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270177\" data-ts=\"1495804670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270177-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16845188-sino-global-continues-strategic-partnerships-two-leading-state-owned-chinese-logistics\" target=\"_blank\">signing</a> of two Project Agreements with Sinotrans Guangxi.</li>     <li><a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='green'>+15%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3270015-nutanix-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a> <font color='green'>+13%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3270027-deckers-outdoor-beats-0_17-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='green'>+10%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> +6% <a href=\"https://seekingalpha.com/news/3270095-big-lots-beats-0_16-misses-revenue\" target=\"_blank\">on Q1 result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/VEEV' title='Veeva Systems Inc.'>VEEV</a> <font color='green'>+6%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3270017-veeva-systems-beats-0_04-beats-revenue\" target=\"_blank\">result</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270177\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SINO $NTNX $DECK - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3270177-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3270177-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270176\" data-ts=\"1495804616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270176-evercore-not-swayed-on-sears-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore not swayed on Sears Holdings</a></h4><ul> <li>Evercore isn't buying into a turnaround for Sears Holdings (SHLD), saying the company is in a \"tenuous\" position.</li> <li>Analyst Greg Melich <a href=\"https://www.nytimes.com/aponline/2017/05/25/business/ap-us-earns-sears-holdings.html\" target=\"_blank\">points</a> to weak sales trends and market losses in major categories in making his assessment.</li> <li>\"Sears does not appear well positioned for the rest of 2017,\" sums up Melich.</li> <li>SHLD <font color='red'>-3.77%</font> premarket after a 14% post-earnings jump yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269850-sears-holdings-rallies-earnings\" target=\"_blank\">Sears Holdings rallies after earnings</a> (May 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270176\" data-linked=\"Evercore not swayed on Sears Holdings\" data-tweet=\"$SHLDQ - Evercore not swayed on Sears Holdings https://seekingalpha.com/news/3270176-evercore-not-swayed-on-sears-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3270176-evercore-not-swayed-on-sears-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270171\" data-ts=\"1495804378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270171-jinko-solarminus-6-morgan-stanley-citi-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jinko Solar -6% as Morgan Stanley, Citi both downgrade</a></h4><ul>     <li>Jinko Solar (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color='red'>-6.1%</font> premarket after being slammed by two downgrades, at Morgan Stanley and Citigroup, following the stock's 41% run-up YTD and 24% during the past week.</li>     <li>Morgan Stanley <a href=\"http://thefly.com/thestreet/realmoney/index.php/JKSid2558540/JKS-JinkoSolar-downgraded-two-notches-to-Underweight-at-Morgan-Stanley\" target=\"_blank\">downgrades JKS two notches</a> to Underweight from Overweight with a $16.40 price target, cut from $19.40, expecting Q1 earnings to decline more than 50% below Wall Street estimates mainly due to lower margins and ASPs, and slow cost reductions given high polysilicon prices and OEM fees.</li>     <li>Stanley thinks the next 12-18 months will be difficult for China solar names, noting increased new capacity coming online, and believes a majority of manufacturers will struggle to reach breakeven in H2 2017 and 2018.</li>     <li>Also, Citigroup <a href=\"http://thefly.com/thestreet/realmoney/index.php/JKSid2558530/JKS-Citi-cuts-JinkoSolar-to-Sell-with-shares-up--this-year\" target=\"_blank\">cuts shares to Sell</a> from Neutral with a $15 price target, trimmed from $15.50, as investors have priced in an \"overly bullish outlook,\" and the firm expects sales declines and margin contraction in Q3 as China's rush installation ends.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270171\" data-linked=\"Jinko Solar -6% as Morgan Stanley, Citi both downgrade\" data-tweet=\"$JKS - Jinko Solar -6% as Morgan Stanley, Citi both downgrade https://seekingalpha.com/news/3270171-jinko-solarminus-6-morgan-stanley-citi-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3270171-jinko-solarminus-6-morgan-stanley-citi-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270169\" data-ts=\"1495804241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270169-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3270018-gamestop-beats-0_12-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3270010-splunk-beats-0_03-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a> <font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16845043-asure-software-acquires-isystems-compass-hrm-announces-public-offering-common-stock\" target=\"_blank\">acquiring</a> iSystems and Compass HRM and announcing public offering of common shares.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3270169\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$GME $JKS $SPLK - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3270169-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3270169-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270167\" data-ts=\"1495804195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270167-best-buyplus-43-ytd-who-called\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Best Buy +43% YTD, here&#39;s who called it</a></h4><ul> <li>Morgan Stanley is still cautious on Best Buy (NYSE:<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a>) after missing out on the recent rally.</li> <li>The firm <a href=\"https://www.streetinsider.com/Analyst+Comments/Best+Buy+%28BBY%29%3A+Staying+On+The+Sidelines+-+Morgan+Stanley/12950076.html\" target=\"_blank\">adjusts</a> its price target to $60, but thinks the expectation implied in Best Buy's share price of the retailer hitting EPS of $5 in 2018 is a reach.</li><li>While Morgan Stanley missed out on the Best Buy +40% YTD run, SA contributor Taylor Dart <a href=\"https://seekingalpha.com/article/4029575-best-buy-gift-keeps-giving\" target=\"_blank\">recommended</a> the stock back in December for technical reasons.</li> <li>Shares of Best Buy are <font color='red'>down 1.1%</font> in premarket trading after rocketing 21.5% yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269805-best-buy-pops-u-s-results-shine\" target=\"_blank\">Best Buy pops after U.S. results shine</a> (May 25)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3270167\" data-linked=\"Best Buy +43% YTD, here&#39;s who called it\" data-tweet=\"$BBY - Best Buy +43% YTD, here&#39;s who called it https://seekingalpha.com/news/3270167-best-buyplus-43-ytd-who-called?source=tweet\" data-url=\"https://seekingalpha.com/news/3270167-best-buyplus-43-ytd-who-called\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270165\" data-ts=\"1495804147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALBO\" target=\"_blank\">ALBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270165-albireo-prices-equity-offering-shares-down-37-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Albireo prices equity offering; shares down 37% premarket</a></h4><ul><li>Thinly traded micro cap Albireo Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ALBO' title='Albireo Pharma, Inc.'>ALBO</a>) slumps&nbsp;<font color='red'>37%</font>&nbsp;premarket, albeit on only 800 shares, in response to the <a href=\"https://seekingalpha.com/pr/16842687-albireo-prices-45_1-million-public-offering-common-stock\" target=\"_blank\">pricing </a>of its public offering of 2.2M shares of common stock at $20.50. Underwriters over-allotment is an additional 330K shares. Closing date is May 30.</li><li>Yesterday's close was $19.14 so the 37% drop is a significant overreach.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270165\" data-linked=\"Albireo prices equity offering; shares down 37% premarket\" data-tweet=\"$ALBO - Albireo prices equity offering; shares down 37% premarket https://seekingalpha.com/news/3270165-albireo-prices-equity-offering-shares-down-37-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270165-albireo-prices-equity-offering-shares-down-37-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270155\" data-ts=\"1495802832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNE\" target=\"_blank\">CLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270155-clean-energy-wins-la-metro-contract-to-fuel-transit-bus-fleet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clean Energy wins LA Metro contract to fuel transit bus fleet</a></h4><ul>     <li>Clean Energy Fuels (NASDAQ:<a href='https://seekingalpha.com/symbol/CLNE' title='Clean Energy Fuels Corp.'>CLNE</a>)&nbsp;<font color='green'>+4.6%</font>&nbsp;premarket on news it was <a href=\"https://seekingalpha.com/pr/16845074-la-metro-awards-multi-year-contract-clean-energy-s-redeem\" target=\"_blank\">awarded a renewable natural gas contract</a> to fuel the Los Angeles County Metropolitan Transportation Authority's fleet of transit buses.</li>     <li>CLNE says it will provide       L.A. Metro with its Redeem brand of RNG, the first renewable and commercially available vehicle fuel made entirely from 100% organic waste.</li>     <li>The contract starts with a one-year pilot to provide Redeem to one of Metro&rsquo;s 11 compressed natural gas stations, which CLNE operates and maintains (every station provides fuel for ~200 CNG buses), with an option to supply the entire fleet of 2,200 natural gas buses for four more years.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270155\" data-linked=\"Clean Energy wins LA Metro contract to fuel transit bus fleet\" data-tweet=\"$CLNE - Clean Energy wins LA Metro contract to fuel transit bus fleet https://seekingalpha.com/news/3270155-clean-energy-wins-la-metro-contract-to-fuel-transit-bus-fleet?source=tweet\" data-url=\"https://seekingalpha.com/news/3270155-clean-energy-wins-la-metro-contract-to-fuel-transit-bus-fleet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270154\" data-ts=\"1495802815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIL\" target=\"_blank\">TRIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270154-trillium-prices-equity-offering-shares-down-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trillium prices equity offering; shares down 8% premarket</a></h4><ul><li>Trillium Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIL' title='Trillium Therapeutics Inc.'>TRIL</a>) <a href=\"https://seekingalpha.com/pr/16845182-trillium-announces-pricing-us-30_0-million-public-offering-common-shares-series-ii-non-voting\" target=\"_blank\">prices </a>its public offering of 2.75M shares of common stock at $5.00 and 3.25M shares of Series II Non-Voting Convertible First Preferred stock at $5.00. Gross proceeds should be ~$30M. Closing date is June 1.</li><li>Net proceeds will fund early-stage studies of SIRP&alpha;Fc (TTI-621), working capital and general corporate purposes.</li><li>Yesterday's close was $5.45.</li><li>Shares are off&nbsp;<font color='red'>8%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270154\" data-linked=\"Trillium prices equity offering; shares down 8% premarket\" data-tweet=\"$TRIL - Trillium prices equity offering; shares down 8% premarket https://seekingalpha.com/news/3270154-trillium-prices-equity-offering-shares-down-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270154-trillium-prices-equity-offering-shares-down-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270146\" data-ts=\"1495801814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIL\" target=\"_blank\">TRIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270146-trading-in-trillium-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Trillium halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended </a>trading in Trillium Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIL' title='Trillium Therapeutics Inc.'>TRIL</a>) pending news. The company is set to release pricing on its offering of common and convertible preferred stock this morning.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270020-trillium-therapeutics-launches-equity-offering-shares-9-percent-hours\" target=\"_blank\">Trillium Therapeutics launches equity offering; shares down 9% after hours</a> (May 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270146\" data-linked=\"Trading in Trillium halted pending news\" data-tweet=\"$TRIL - Trading in Trillium halted pending news https://seekingalpha.com/news/3270146-trading-in-trillium-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3270146-trading-in-trillium-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270140\" data-ts=\"1495800261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASFI\" target=\"_blank\">ASFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270140-asta-funding-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asta Funding reports Q1 results</a></h4><ul><li>Asta Funding (NASDAQ:<a href='https://seekingalpha.com/symbol/ASFI' title='Asta Funding, Inc.'>ASFI</a>): Q1 EPS of -$0.57</li><li>Revenue of $8.27M (-21.8% Y/Y)</li><li>Shares <font color='green'>+10.4%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16845143-asta-funding-announces-results-second-quarter-ended-march-31-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270140\" data-linked=\"Asta Funding reports Q1 results\" data-tweet=\"$ASFI - Asta Funding reports Q1 results https://seekingalpha.com/news/3270140-asta-funding-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3270140-asta-funding-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270139\" data-ts=\"1495800151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZOES\" target=\"_blank\">ZOES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270139-zoes-kitchen-sinks-to-52-week-low-weak-sales-trend-persists\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoe&#39;s Kitchen sinks to 52-week low as weak sales trend persists</a></h4><ul> <li>Zoe's Kitchen (NYSE:<a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a>) trades lower after reporting a 3.3% drop in comparable sales in <a href=\"https://seekingalpha.com/pr/16844781-zoes-kitchen-announces-first-quarter-2017-results\" target=\"_blank\">Q1</a> amid what it calls a \"challenging traffic\" backdrop.</li> <li>Looking ahead at the full year, Zoe's expects revenue of $314M to $322M vs. $324M consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270019-zoes-eps-line-misses-revenue\" target=\"_blank\">Zoe's EPS in-line, misses on revenue</a> (May 25)</li>  <li>ZOES <font color='red'>-10.80%</font>&nbsp;premarket to $14.45 (52-week low).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270139\" data-linked=\"Zoe&#39;s Kitchen sinks to 52-week low as weak sales trend persists\" data-tweet=\"$ZOES - Zoe&#39;s Kitchen sinks to 52-week low as weak sales trend persists https://seekingalpha.com/news/3270139-zoes-kitchen-sinks-to-52-week-low-weak-sales-trend-persists?source=tweet\" data-url=\"https://seekingalpha.com/news/3270139-zoes-kitchen-sinks-to-52-week-low-weak-sales-trend-persists\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270132\" data-ts=\"1495798941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPIC\" target=\"_blank\">TPIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270132-tpi-compositesminus-9-on-news-ge-will-not-extend-supply-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TPI Composites -9% on news GE will not extend supply agreement</a></h4><ul>     <li>TPI Composites (NASDAQ:<a href='https://seekingalpha.com/symbol/TPIC' title='TPI Composites'>TPIC</a>) <font color='red'>-9.1%</font> premarket after disclosing that GE <a href=\"https://seekingalpha.com/filing/3567715\" target=\"_blank\">will not extend its supply agreement</a> for wind turbine blades from the company&rsquo;s manufacturing facility in Taicang, China, beyond the end of this year.</li><li>TPIC says it will remain an outsourced supplier for GE and continue to execute on its contracts with GE in the U.S. and Mexico.</li><li>In an <a href=\"http://s21.q4cdn.com/635504763/files/doc_presentations/2017/May/TPIC-Company-Presentation-Post-GE-vF.pdf\" target=\"_blank\">investor presentation</a> released after the GE news, TPIC says existing contracts provide for ~$4.2B in revenue through 2023.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270132\" data-linked=\"TPI Composites -9% on news GE will not extend supply agreement\" data-tweet=\"$TPIC - TPI Composites -9% on news GE will not extend supply agreement https://seekingalpha.com/news/3270132-tpi-compositesminus-9-on-news-ge-will-not-extend-supply-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3270132-tpi-compositesminus-9-on-news-ge-will-not-extend-supply-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270130\" data-ts=\"1495798810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270130-caution-from-analysts-follows-dazzling-ulta-salon-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caution from analysts follows dazzling Ulta Salon numbers</a></h4><ul> <li>Ulta Salon (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a>) dazzles again with its quarterly numbers (comparable sales +14%, e-commerce +71%), but the run-up in share price has some analysts exuding caution.</li><li>Buckingham Research downgrades Ulta Salon (<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a>) to a Neutral rating after having the retailer locked in at Buy.</li> <li>The analyst team indicates in a <a href=\"https://twitter.com/BuckResearch/status/868062434963181568\" target=\"_blank\">tweet</a> that the move to the sidelines is tied to a balanced risk/reward profile on Ulta and its view that EPS upside is largely priced in.</li> <li>Deutsche Bank is also conservative on Ulta, boosting its price target to $300 while sticking with a Neutral rating.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270012-ulta-beauty-beats-0_11-beats-revenue\" target=\"_blank\">Ulta Beauty beats by $0.11, beats on revenue</a> (May 25)</li> <li>ULTA <font color='green'>+2.72%</font> premarket to $301.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270130\" data-linked=\"Caution from analysts follows dazzling Ulta Salon numbers\" data-tweet=\"$ULTA - Caution from analysts follows dazzling Ulta Salon numbers https://seekingalpha.com/news/3270130-caution-from-analysts-follows-dazzling-ulta-salon-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3270130-caution-from-analysts-follows-dazzling-ulta-salon-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270129\" data-ts=\"1495798485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270129-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Vanda Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a>) <a href=\"https://thefly.com/landingPageNews.php?id=2558491&amp;headline=VNDA-Vanda-initiated-\" target=\"_blank\">initiated </a>with Buy rating and $18 (29% upside) price target by H.C. Wainwright. Analyst cites \"solid base business\" with Fanapt and Hetlioz and \"substantial upside\" with pipeline. Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket but only on 40 shares.</li><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>) <a href=\"https://thefly.com/landingPageNews.php?id=2558488&amp;headline=BDSI-BioDelivery-Sciences-initiated-\" target=\"_blank\">initiated </a>with a Buy rating and $4 (82% upside) price target by H.C. Wainwright. Analyst cites \"revitalized organization\" with a \"differentiated growth driver.\" Shares are up&nbsp;<font color='green'>5%&nbsp;</font>premarket on light volume.</li><li>Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) <a href=\"https://thefly.com/landingPageNews.php?id=2558485&amp;headline=IMMU-Immunomedics-initiated-\" target=\"_blank\">initiated </a>with Outperform rating and $15 (101% upside) price target by Cowen and Company. Analyst cites compelling Phase 2 data for IMMU-132 for triple negative breast cancer that should make it the standard of care. Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket on average volume.</li><li>Zoetis (NYSE:<a href='https://seekingalpha.com/symbol/ZTS' title='Zoetis'>ZTS</a>) initiated with Buy rating and $71 (13% upside) price target by C.L. King.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270129\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$VNDA $VNDA $BDSI - Premarket analyst action - healthcare https://seekingalpha.com/news/3270129-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3270129-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270097\" data-ts=\"1495793513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIG\" target=\"_blank\">BIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270097-big-lots-positive-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big Lots positive post Q1 results</a></h4><ul>     <li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) reports comparable-store sales fell 0.9% in <a href=\"https://seekingalpha.com/pr/16845075-big-lots-reports-record-first-quarter-earnings-1_15-per-diluted-share\" target=\"_blank\">Q1</a>, missed the Company's guidance of flat to an increase of 2%.</li>     <li>Gross margin rate improved 100 bps to 40.4%.</li>     <li>Adjusted SG&amp;A expense rate down 10 bps to 32.1%.</li>     <li>Adjusted operating margin rate rose 120 bps to 6.1%.</li>     <li>Inventory +3.6% Y/Y to $836.12M.</li>     <li><b>Q2 Guidanc</b>e:&nbsp;Comparable-store sales:&nbsp;increase in the low single digit range;&nbsp;Adjusted&nbsp;EPS: $0.58 to $0.63 (+12% to +21%).</li>     <li><b>FY2017 Guidance</b>: Total sales:&nbsp;flat to up slightly&nbsp;Y/Y; Comparable-store sales: +1% to +2%; Adjusted&nbsp;EPS:&nbsp;$4.05 to $4.20 (+11% to +15%); Cash flow: ~$180M to $190M.</li><li>BIG&nbsp;<font color='green'>+4.71%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270097\" data-linked=\"Big Lots positive post Q1 results\" data-tweet=\"$BIG - Big Lots positive post Q1 results https://seekingalpha.com/news/3270097-big-lots-positive-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3270097-big-lots-positive-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270095\" data-ts=\"1495792909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIG\" target=\"_blank\">BIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270095-big-lots-beats-0_16-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big Lots beats by $0.16, misses on revenue</a></h4><ul><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>): Q1 EPS of $1.15 <font color='green'>beats by $0.16</font>.</li><li>Revenue of $1.3B (-0.8% Y/Y) <font color='red'>misses by $10M</font>.</li><li>Shares <font color='green'>+4.4%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16845075-big-lots-reports-record-first-quarter-earnings-1_15-per-diluted-share'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270095\" data-linked=\"Big Lots beats by $0.16, misses on revenue\" data-tweet=\"$BIG - Big Lots beats by $0.16, misses on revenue https://seekingalpha.com/news/3270095-big-lots-beats-0_16-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3270095-big-lots-beats-0_16-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 AM </div></div></li>","count":42,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}